We demonstrate that both standard SHH-GLI inhibitor cyclopamine and the novel more specific inhibitor of smoothened NVP-LDE225 reduce the GLI1 promoter activity, induce G1 cell cycle arrest, and induce apoptosis in human melanoma cell lines. The gene discussed is SHH; the disease is melanoma.